These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5045922)

  • 21. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intravenous chemotherapy of pulmonary tuberculosis].
    Ivaniuta OM
    Vrach Delo; 1971 Jan; (1):84-7. PubMed ID: 4325153
    [No Abstract]   [Full Text] [Related]  

  • 23. What about short course and intermittent chemotherapy for tuberculosis in children?
    Smith MH
    Pediatr Infect Dis; 1982; 1(5):298-303. PubMed ID: 6984178
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 25. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
    Suzuki T
    Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
    Tsukamura M; Yoshii S; Yasuda Y; Saito H
    Kekkaku; 1986 Jan; 61(1):15-7. PubMed ID: 3458966
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV; Gavrilenko VS; Tarasova EF; Sokolova GV; Tregubov IuG
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 32. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effectiveness of regional lymphotropic therapy in combined treatment of tuberculosis in adolescents].
    Gubkina MF
    Probl Tuberk; 1996; (3):34-7. PubMed ID: 8754878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complex hospital treatment of pulmonary tuberculosis].
    Bondarev IM; Batmanov NIa; Shesterina MV; Gavrilenko VS; Tarasova EF
    Sov Med; 1980; (6):79-82. PubMed ID: 6998023
    [No Abstract]   [Full Text] [Related]  

  • 35. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
    Ershov AI; Tikhonov VA; Grigaliunas AP; Sushkin AG; Guzeeva SA
    Vrach Delo; 1981 May; (5):21-5. PubMed ID: 7257254
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J
    Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract]   [Full Text] [Related]  

  • 39. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ
    Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A; Gaik A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.